CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 119 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,275,073 | +679.0% | 177,373 | +372.0% | 0.00% | – |
| Q2 2023 | $677,138 | +9.8% | 37,577 | -2.2% | 0.00% | – |
| Q1 2023 | $616,865 | +84.4% | 38,410 | +110.1% | 0.00% | – |
| Q4 2022 | $334,543 | -8.6% | 18,281 | -2.0% | 0.00% | – |
| Q3 2022 | $366,000 | -6.2% | 18,647 | -10.9% | 0.00% | – |
| Q2 2022 | $390,000 | -8.2% | 20,919 | +8.1% | 0.00% | – |
| Q1 2022 | $425,000 | -92.1% | 19,343 | -89.8% | 0.00% | -100.0% |
| Q4 2021 | $5,404,000 | +1457.3% | 190,235 | +1052.9% | 0.00% | – |
| Q3 2021 | $347,000 | +34.5% | 16,501 | +20.4% | 0.00% | – |
| Q2 2021 | $258,000 | – | 13,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |